title: [Main therapeutic advances in IBD in 2008].
abstract: A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia.
authors.affiliation: Service de gastroentérologie et d'hépatologie, CHUV, Lausanne.
authors.forename: C
authors.initials: C
authors.lastname: Felley
authors.forename: C
authors.initials: C
authors.lastname: Mottet
authors.forename: J
authors.initials: J
authors.lastname: Hess
authors.forename: M H
authors.initials: MH
authors.lastname: Maillard
authors.forename: J
authors.initials: J
authors.lastname: Delarive
authors.forename: P
authors.initials: P
authors.lastname: Michetti
mesh_terms: D018890:Chemoprevention; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha